3 June 2016

2015 Annual Report and Accounts, Notice of AGM

PR Newswire

Read more

27 May 2016

Notice of Results

VERONA PHARMA PLC - Notice of Results

Read more

4 May 2016

Verona to present RPL554 at the ATS Conference

VERONA PHARMA PLC - Verona to present RPL554 at the ATS Conference

Read more

19 April 2016

Change of Registered Office

VERONA PHARMA PLC - Change of Registered Office

Read more

15 April 2016

Holding(s) in Company

 

Read more

21 March 2016

Verona Pharma: 2015 in review

VERONA PHARMA PLC - Verona Pharma: 2015 in review

Read more

15 March 2016

Positive results from RPL554 dose-finding study

VERONA PHARMA PLC - Positive results from RPL554 dose-finding study

Read more

10 February 2016

Grant of Share Options

VERONA PHARMA PLC - Grant of Share Options

Read more

21 January 2016

Director Dealing

Verona Pharma plc

Read more

11 January 2016

Directorate Change

VERONA PHARMA PLC - Directorate Change

Read more

Targeting unmet needs

384m people worldwide suffer from COPD and 37 years is the median life expectancy of CF patients

Read more about COPD and CF in the unmet needs section of this website

Go

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us